Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
  1. 4 Shares withheld for taxes President and CEO gave up 3,455 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Scientific Officer gave up 1,480 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Financial Officer gave up 1,480 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Reg & Develop Officer gave up 1,480 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Commercial Officer gave up 1,153 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Legal Officer gave up 1,974 shares (to pay taxes)
  7. 4 Open-market buy Chief Financial Officer bought 1,250 shares at $18.22 ($22,775)
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market buy Chief Financial Officer bought 1,250 shares at $16.59 ($20,738)
  12. 4 Open-market buy Director bought 26,700 shares at $16.54 ($441,618)
  13. 4 Open-market sale Director sold 2,300 shares at $16.52 ($37,996)
  14. 4 Open-market buy President and CEO bought 10,000 shares at $16.75 ($167,500)
  15. 4 Exercise or conversion Director acquired 2,377 shares (option exercise)
  16. 4 Other disposition Director disposed of 94,151 shares (other)
  17. 4 Other acquisition Chief Legal Officer acquired 9,018 shares (other)
  18. 4 Other acquisition Chief Financial Officer acquired 9,018 shares (other)
  19. 4 Other acquisition President and CEO acquired 9,018 shares (other)
  20. 4 Derivatives Options or other derivatives

Page 16 of 21 · 414 filings